display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - adjuvant
breast cancer - adjuvant
HER inhibitor
HER2 inhibitor
neratinib based treatment
neratinib ExteNET
pertuzumab based treatment
pertuzumab plus trastuzumab APHINITY
trastuzumab based treatment
docetaxel plus carboplatin with trastuzumab followed by trastuzumab BCIRG-006 ...
doxorubicin plus cyclophosphamide followed by docetaxel plus trastuzumab BCIRG-006 ... BCIRG-006 ...

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons